Multiplexed Diagnostic Market Share Growing Rapidly with Recent Trends, Development, Revenue, Demand and Forecast 2019 - 2027

                                                                            
Multiplexed diagnostics are used to examine biological samples and complete a screening process in a single run.

                Multiplexed Diagnostic Market


Multiplexed diagnostics are used to examine biological samples and complete a screening process in a single run. Multiplexed diagnostic tests are used to detect and diagnose diseases and infections such as cancer, allergies, autoimmune diseases, and cardiovascular disease. The number of analytes examined in a single assay varies according to multiplex equipment technology and can range from 5 to 10,000 analytes. Early detection of infectious disorders reduces the risk of infection and aids in effective treatment. Multiplexed diagnostic assays have advantages such as high accuracy and precision, and they can look for flaws and mutations in any functional biomolecule such as protein, RNA, or DNA.

The increasing occurrence of disease outbreaks is expected to drive market growth during the forecast period. The rising prevalence of disease outbreaks such as coronavirus and Ebola virus is increasing demand for advanced diagnostic measures, which is expected to drive growth in the multiplexed diagnostic market. The most recent outbreak, for example, is the coronavirus disease, which was first reported on December 31, 2019 in Wuhan, China. On March 1, 2020, the World Health Organization (WHO) reported 87,137 cases of coronavirus disease worldwide.

The lack of skilled labour and the high cost of multiplexed diagnostics assays may limit market growth. Furthermore, when compared to conventional diagnostic tests, the reimbursement structure for diagnostics tests that use multiplexed assays is unclear by both private and public payers, which may restrain the global multiplexed diagnostics market.

Market Segmentation:

By Technology

  • Low Density Multiplexed Assays
  • Medium Density Multiplexed Assays
  • High Density Multiplexed Assays
  • Very High Density Multiplexed Assays
  • Next-Generation Sequencing Assays

By Application

  • Infectious Disease Diagnostics
  • Oncology, Autoimmune Diseases
  • Cardiac Diseases
  • Allergies

By End User
  • Academic Research Institutes
  • Hospitals
  • Pharmaceuticals Companies
  • Clinical Research Organizations
  • Diagnostic Laboratories
The major players operating in the global multiplexed diagnostic market include Luminex Corporation, Thermo Fisher, Illumine Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthineers, Agilent technologies, BioMerieux SA, and F.Hoffmann-La Roche Ltd.

Comments

Popular posts from this blog

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.

Biolubricants Market Size, Share, Growth, Opportunities, Global Analysis and Opportunity Assessment 2019 – 2027

Shared Services Market by Function, By Number of Services and By Region – Global Opportunities & Forecast 2019 - 2027